Inge Vliegen
- Hepatology top 2%
- Hepatitis C virus research 20
- Epidemiology top 5%
- Hepatitis B Virus Studies 8
- Cytomegalovirus and herpesvirus research 7
- Virology top 5%
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 10
- Immunology top 10%
- Atherosclerosis and Cardiovascular Diseases 6
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 3
-
- Signaling Pathways in Disease 4
- Biochemical and Molecular Research 3
- Co-authors
- Johan NeytsErik De ClercqJan PaeshuyseArmando M. De PalmaFrank StassenCathrien A. BruggemanLotte CoelmontGert Grauls
- Cited by
- HepatologyEpidemiologyVirology
- Journals
- Antiviral Research (7 papers)Journal of Hepatology (3 papers)Antimicrobial Agents and Chemotherapy (3 papers)
- Partner nations
- BelgiumNetherlandsUnited States
In The Last Decade
Inge Vliegen
31 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 89
- Hepatology 408
- Epidemiology 592
- Virology 80
- Infectious Diseases 278
- Immunology 249
Countries citing papers authored by Inge Vliegen
This map shows the geographic impact of Inge Vliegen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge Vliegen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge Vliegen more than expected).
Fields of papers citing papers by Inge Vliegen
This network shows the impact of papers produced by Inge Vliegen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge Vliegen. The network helps show where Inge Vliegen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Inge Vliegen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 5 | |
| 2 | 2013 | 3 | |
| 3 | 2013 | 31 | |
| 4 | 2013 | 64 | |
| 5 | 2011 | 20 | |
| 6 | 2011 | 13 | |
| 7 | 2010 | 143 | |
| 8 | 2009 | 89 | |
| 9 | 2009 | 35 | |
| 10 | 2008 | 199 | |
| 11 | 2007 | 178 | |
| 12 | 2007 | 9 | |
| 13 | 2006 | 57 | |
| 14 | 2006 | 62 | |
| 15 | 2005 | 18 | |
| 16 | 2004 | 32 | |
| 17 | 2003 | 25 | |
| 18 | 2002 | 44 | |
| 19 | 2002 | 33 | |
| 20 | Cytomegalovirus (CMV) infection accelerates the development of atherosclerosis in apolipoproteinE (apoE) knock-out mice | 2000 | 0 |
About Inge Vliegen
Inge Vliegen is a scholar working on Hepatology, Infectious Diseases and Virology, having authored 33 papers that have together received 1.4k indexed citations. Recurring topics across this work include Hepatitis C virus research (20 papers), HIV/AIDS drug development and treatment (10 papers), Hepatitis B Virus Studies (8 papers), Cytomegalovirus and herpesvirus research (7 papers), Atherosclerosis and Cardiovascular Diseases (6 papers), Signaling Pathways in Disease (4 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers) and Biochemical and Molecular Research (3 papers). The work is most often cited by research in Hepatology (408 citations), Epidemiology (592 citations) and Virology (80 citations). Inge Vliegen has collaborated with scholars based in Belgium, Netherlands and United States. Frequent co-authors include Johan Neyts, Erik De Clercq, Jan Paeshuyse, Armando M. De Palma, Frank Stassen, Cathrien A. Bruggeman, Lotte Coelmont, Gert Grauls, Leen Delang and Jih Ru Hwu. Their work appears in journals such as Antiviral Research, Journal of Hepatology, Antimicrobial Agents and Chemotherapy, Microbes and Infection and Journal of Clinical Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.